samarium has been researched along with technetium tc 99m medronate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ketring, AR | 1 |
Addison, SJ; Appelbaum, F; Baker, M; Collins, C; Eary, JF; Ferency, S; Hartnett, S; Petersdorf, S; Stabin, M; Vernon, C | 1 |
1 trial(s) available for samarium and technetium tc 99m medronate
Article | Year |
---|---|
Samarium-153-EDTMP biodistribution and dosimetry estimation.
Topics: Bone Neoplasms; Chelating Agents; Humans; Male; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiotherapy Dosage; Samarium; Technetium Tc 99m Medronate; Tissue Distribution | 1993 |
1 other study(ies) available for samarium and technetium tc 99m medronate
Article | Year |
---|---|
153Sm-EDTMP and 186Re-HEDP as bone therapeutic radiopharmaceuticals.
Topics: Animals; Bone Neoplasms; Dogs; Etidronic Acid; Humans; Kinetics; Organophosphorus Compounds; Pain; Rabbits; Radioisotopes; Radionuclide Imaging; Rhenium; Samarium; Technetium Tc 99m Medronate; Tissue Distribution | 1987 |